<qa>  What is the objective response rate in patients with metastatic pancreatic cancer treated with?I. To determine the objective response rate in patients with metastatic pancreatic cancer treated with concurrent gemcitabine and BAY43-9006 and sequential BAY 43-9006 followed by gemcitabineBAY 43-9006 at progression. 